UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Microsoft
MSFT
|
+$3.04B |
| 2 |
Apple
AAPL
|
+$2B |
| 3 |
NVIDIA
NVDA
|
+$1.79B |
| 4 |
Amazon
AMZN
|
+$1.24B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.03B |
Top Sells
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$555M |
| 2 |
Schlumberger
SLB
|
+$482M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$362M |
| 4 |
iShares Gold Trust
IAU
|
+$322M |
| 5 |
CRH
CRH
|
+$213M |
Sector Composition
| 1 | Technology | 20.26% |
| 2 | Financials | 10.32% |
| 3 | Healthcare | 8.24% |
| 4 | Consumer Discretionary | 7.26% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Relmada Therapeutics
RLMD
$50.8M
| $601K | ﹤0.01% |
129,285
+3,555
| +3% | +$16.5K |
|
3952
Nabors Industries
NBR
$548M
| $601K | ﹤0.01% |
6,979
+719
| +11% | +$61.9K |
|
3953
Accuray
ARAY
$188M
| $600K | ﹤0.01% |
242,825
-21,105
| -8% | -$52.1K |
|
3954
CAE Inc
CAE
$8.96B
| $600K | ﹤0.01% |
29,054
+15,635
| +117% | +$323K |
|
3955
Harrow
HROW
$1.64B
| $599K | ﹤0.01% |
45,251
-62
| -0.1% | -$820 |
|
3956
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$347M
| $598K | ﹤0.01% |
11,190
+885
| +9% | +$47.3K |
|
3957
Amylyx Pharmaceuticals
AMLX
$1.42B
| $598K | ﹤0.01% |
210,573
+171,559
| +440% | +$487K |
|
|
WSR
3958
Whitestone REIT
WSR
$649M
| $598K | ﹤0.01% |
47,625
-7,891
| -14% | -$99K |
|
3959
FlexShares STOXX Global ESG Select Index Fund
ESGG
$98.2M
| $597K | ﹤0.01% |
3,668
+45
| +1% | +$7.33K |
|
3960
ProFrac Holding
ACDC
$649M
| $597K | ﹤0.01% |
71,363
-15,963
| -18% | -$133K |
|
3961
Nano X Imaging
NNOX
$254M
| $596K | ﹤0.01% |
61,033
-21,663
| -26% | -$212K |
|
3962
Safe Bulkers
SB
$464M
| $596K | ﹤0.01% |
120,182
+25,589
| +27% | +$127K |
|
3963
Daily Journal
DJCO
$617M
| $596K | ﹤0.01% |
1,648
-67
| -4% | -$24.2K |
|
3964
nCino
NCNO
$3.43B
| $596K | ﹤0.01% |
15,940
-16,118
| -50% | -$602K |
|
3965
SPDR S&P Telecom ETF
XTL
$158M
| $594K | ﹤0.01% |
8,000
+135
| +2% | +$10K |
|
3966
NCR Atleos
NATL
$2.86B
| $594K | ﹤0.01% |
30,057
+24,365
| +428% | +$481K |
|
3967
Diamond Hill
DHIL
$382M
| $593K | ﹤0.01% |
3,846
+301
| +8% | +$46.4K |
|
3968
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$53.8M
| $592K | ﹤0.01% |
28,591
-3,037
| -10% | -$62.9K |
|
|
AUTL
3969
Autolus Therapeutics
AUTL
$357M
| $592K | ﹤0.01% |
92,848
+8,193
| +10% | +$52.3K |
|
|
NBIS
3970
Nebius Group N.V.
NBIS
$24.8B
| $592K | ﹤0.01% |
39,704
-296,962
| -88% | -$4.43M |
|
3971
Dine Brands
DIN
$354M
| $590K | ﹤0.01% |
12,686
+11,580
| +1,047% | +$538K |
|
3972
LivePerson
LPSN
$97.5M
| $590K | ﹤0.01% |
591,365
-25,980
| -4% | -$25.9K |
|
3973
BrightSpring Health Services
BTSG
$4.84B
| $589K | ﹤0.01% |
+54,219
| New | +$589K |
|
3974
Fulgent Genetics
FLGT
$683M
| $589K | ﹤0.01% |
27,130
-3,737
| -12% | -$81.1K |
|
|
MPV
3975
Barings Participation Investors
MPV
$216M
| $589K | ﹤0.01% |
36,519
-12,917
| -26% | -$208K |
|